Prescription drug · NDA
Emend (Aprepitant) NDC 0006-3862
Kit · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-3862-03 | 00006386203 | 1 KIT in 1 DOSE PACK (0006-3862-03) * 1 CAPSULE in 1 CAPSULE * 1 CAPSULE in 1 CAPSULEMarketed from Mar 26, 2003 | |
| 0006-3862-13 | 00006386213 | 1 KIT in 1 DOSE PACK (0006-3862-13) * 1 CAPSULE in 1 CAPSULE * 1 CAPSULE in 1 CAPSULEMarketed from Mar 26, 2003 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Emend
- Generic name (nonproprietary)
- aprepitant
- Dosage form
- Kit
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021549
- Marketing start
- Listing expires
- Identifiers
- Product ID 0006-3862_428f7828-6d1c-438b-a17d-b4af0700c740SPL ID 428f7828-6d1c-438b-a17d-b4af0700c740SPL set ID 696f9e80-9cae-403b-de9e-078343ce4713RxCUI 403810, 403811, 404465, 404466, 644088, 644278, 754508, 754509, 1729308, 1729311UNII 1NF15YR6UY
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400006386203followed by a unit qualifier and the quantityPackage 00006-3862-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EMEND ® for oral suspension, in combination with other antiemetic agents, is indicated in patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). EMEND ® capsules, in combination with other antiemetic agents, is indicated in patients 12 years of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including hig…
Excerpt only. Read the full label for complete information.
About NDC 0006-3862
- What is NDC 0006-3862?
- 0006-3862 is the product NDC for Emend (aprepitant) kit, listed with the FDA by Merck Sharp & Dohme LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Emend (Aprepitant).
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Emend?
- 5 other product NDCs are listed under this name. See all Emend NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Emend products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Emendfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0006-3061 | 00006-3061-00 |
| Emendaprepitant | Aprepitant 125 mg/1 | Powder, For suspensionOral | Merck Sharp & Dohme LLC | 0006-3066 | 00006-3066-03 |
| Emendaprepitant | Aprepitant 125 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0462 | — |
| Emendaprepitant | Aprepitant 40 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0464 | — |
| Emendaprepitant | Aprepitant 80 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0461 | 00006-0461-0200006-0461-12 |
Other NDCs under NDA 021549
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Emendaprepitant | Aprepitant 125 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0462 |
| Emendaprepitant | Aprepitant 40 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0464 |
| Emendaprepitant | Aprepitant 80 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0461 |